Literature DB >> 16641660

The impact of physician attitudes and beliefs on treatment decisions: lipid therapy in high-risk patients.

Kathleen A Foley1, Margo A Denke, Sachin Kamal-Bahl, Ross Simpson, Kathy Berra, Shiva Sajjan, Charles M Alexander.   

Abstract

BACKGROUND: Despite clinical guidelines, many patients with hypercholesterolemia do not achieve treatment goals in clinical practice.
OBJECTIVES: This study examined physician attitudes and beliefs about hyperlipidemia and whether they are associated with lipid treatment decisions.
METHODS: This was a cross-sectional study of 107 physicians who completed a validated survey of attitudes and beliefs about hyperlipidemia and provided treatment histories for 1187 statin-treated patients with coronary heart disease (CHD) or who were CHD risk-equivalent. Logistic regressions (using generalized estimating equation) estimated the impact of patient characteristics and physician attitudes and beliefs on whether a patient received increases in the statin dose.
RESULTS: Approximately 70% of the 843 patients who were not at low-density lipoprotein cholesterol goal (<100 mg/dL) with initial statin therapy received a dose increase, although only one-half attained goal. Controlling for patient characteristics, patients whose physicians believed "close enough to goal is good enough" had 47% lower odds of having a dose increase (odds ratio [OR], 0.53; 95% confidence interval [CI], 0.34-0.82), whereas patients whose physicians believed "statins are effective" had almost twice the odds of having a dose increase (OR, 1.78; 95% CI, 1.05-3.00).
CONCLUSIONS: Although the understanding of basic and clinical science remains fundamental, clinical guideline authors may want to consider the importance of physician attitudes and beliefs in determining translation of their guidelines into clinical practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16641660     DOI: 10.1097/01.mlr.0000208017.18278.1a

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  9 in total

1.  Early discontinuation: more frequent among general practitioners with high levels of prescribing.

Authors:  Dorte Gilså Hansen; Anthony Gichangi; Werner Vach; Lina Hoel Felde; John Larsen
Journal:  Eur J Clin Pharmacol       Date:  2007-07-06       Impact factor: 2.953

2.  Care pathways in early rheumatoid arthritis.

Authors:  Sasha Bernatsky; Debbie Feldman; Ian Shrier; Karine Toupin; Jeannie Haggerty; Pierre Tousignant; Michel Zummer
Journal:  Can Fam Physician       Date:  2006-11       Impact factor: 3.275

3.  A taxonomy of reasons for not prescribing guideline-recommended medications for patients with heart failure.

Authors:  Michael A Steinman; Sneha Patil; Priya Kamat; Carolyn Peterson; Sara J Knight
Journal:  Am J Geriatr Pharmacother       Date:  2010-12

4.  Primary care physicians' perspectives towards managing rheumatoid arthritis: room for improvement.

Authors:  Katie L Garneau; Maura D Iversen; Hsun Tsao; Daniel H Solomon
Journal:  Arthritis Res Ther       Date:  2011-11-18       Impact factor: 5.156

Review 5.  Unmet need in the hyperlipidaemia population with high risk of cardiovascular disease: a targeted literature review of observational studies.

Authors:  S Mitchell; S Roso; M Samuel; M Pladevall-Vila
Journal:  BMC Cardiovasc Disord       Date:  2016-04-26       Impact factor: 2.298

6.  Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey.

Authors:  Michel Krempf; Ross J Simpson; Dena Rosen Ramey; Philippe Brudi; Hilde Giezek; Joanne E Tomassini; Raymond Lee; Michel Farnier
Journal:  Lipids Health Dis       Date:  2015-05-19       Impact factor: 3.876

7.  Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study.

Authors:  Elisabeth AB; Petra Denig; Ton van Vliet; Janny H Dekker
Journal:  BMC Fam Pract       Date:  2009-04-21       Impact factor: 2.497

8.  Sharing Physician Notes Through an Electronic Portal is Associated With Improved Medication Adherence: Quasi-Experimental Study.

Authors:  Eric Wright; Jonathan Darer; Xiaoqin Tang; Jason Thompson; Lorraine Tusing; Alan Fossa; Tom Delbanco; Long Ngo; Jan Walker
Journal:  J Med Internet Res       Date:  2015-10-08       Impact factor: 5.428

9.  Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease.

Authors:  Nitya Bakshi; Cynthia B Sinha; Diana Ross; Kirshma Khemani; George Loewenstein; Lakshmanan Krishnamurti
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.